Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Kite Pharma Inc (NASDAQ:KITE)

50.75
Delayed Data
As of Jul 22
 +0.57 / +1.14%
Today’s Change
38.41
Today|||52-Week Range
89.84
-17.64%
Year-to-Date

Today’s Trading

Previous close50.18
Today’s open50.23
Day’s range49.66 - 51.10
Volume324,063
Average volume (3 months)898,571
Market cap$2.5B
Dividend yield--
Data as of 3:59pm ET, 07/22/2016

Growth & Valuation

Earnings growth (last year)-21.99%
Earnings growth (this year)-143.84%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales155.81
Price/Book4.01

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+1.14+1.81%
XONIntrexon Corp-0.32-1.32%
NVAXNovavax Inc-0.09-1.21%
JUNOJuno Therapeutics In...+0.30+1.04%
Data as of 4:01pm ET, 07/22/2016

Financials

Next reporting dateAugust 11, 2016
EPS forecast (this quarter)-$1.22
Annual revenue (last year)$17.3M
Annual profit (last year)-$101.7M
Net profit margin-589.02%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President &
Chief Executive Officer
Arie S. Belldegrun
Chief Operating Officer
Cynthia M. Butitta
Corporate headquarters
Santa Monica, California

Forecasts

Partner Offers

Search for Jobs